Clinical characteristics and pathophysiological mechanisms of focal and diffuse traumatic brain injury

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 10, 2010, Pages 2381-2392

  Andriessen, Teuntje M J C ^a   Jacobs, Bram ^a   Vos, Pieter E ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Axonal disconnection; Diffuse traumatic brain injury; Excitotoxicity; Focal traumatic brain injury; Mitochondria; Pathophysiology; Traumatic axonal injury

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CALPAIN; CASPASE; EXCITATORY AMINO ACID; GLUTAMIC ACID;

ARTICLE; BRAIN EDEMA; BRAIN INJURY; CLASSIFICATION; DIFFUSE AXONAL INJURY; GLASGOW COMA SCALE; HUMAN; INJURY SCALE; METABOLISM; MITOCHONDRION; NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY;

BRAIN EDEMA; BRAIN INJURIES; CALPAIN; CASPASES; DIFFUSE AXONAL INJURY; EXCITATORY AMINO ACIDS; GLASGOW COMA SCALE; GLUTAMIC ACID; HUMANS; INJURY SEVERITY SCORE; MAGNETIC RESONANCE IMAGING; MITOCHONDRIA; NECROSIS; NEUROTRANSMITTER AGENTS;

ANIMALIA;

EID: 77958616470     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01164.x     Document Type: Article

References (140)

1. Tagliaferri F, Compagnone C, Korsic M, et al A systematic review of brain injury epidemiology in Europe. Acta Neurochir. 2006; 148: 255-68.
2. Rutland-Brown W, Langlois JA, Thomas KE, et al Incidence of traumatic brain injury in the United States, 2003. J Head Trauma Rehabil. 2006; 21: 544-8.
3. Murray GD, Teasdale GM, Braakman R, et al The European Brain Injury Consortium survey of head injuries. Acta Neurochir. 1999; 141: 223-36.
4. Cremer OL, Moons KG, Van Dijk GW, et al Prognosis following severe head injury: development and validation of a model for prediction of death, disability, and functional recovery. J Trauma. 2006; 61: 1484-91.
5. Myburgh JA, Cooper DJ, Finfer SR, et al Epidemiology and 12-month outcomes from traumatic brain injury in australia and new zealand. J Trauma. 2008; 64: 854-62.
6. Tolias CM, Bullock MR. Critical appraisal of neuroprotection trials in head injury: what have we learned NeuroRx. 2004; 1: 71-9.
7. Schouten JW. Neuroprotection in traumatic brain injury: a complex struggle against the biology of nature. Curr Opin Crit Care. 2007; 13: 134-42.
8. Teasdale GM, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974; 2: 81-4.
9. Steyerberg EW, Mushkudiani N, Perel P, et al Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics. PLoS Med. 2008; 5: 1251-61.
10. Chesnut RM, Marshall LF, Klauber MR, et al The role of secondary brain injury in determining outcome from severe head injury. J Trauma. 1993; 34: 216-22.
11. Graham DI, Adams JH, Doyle D, et al Quantification of primary and secondary lesions in severe head injury. Acta Neurochir Suppl. 1993; 57: 41-8.
12. Povlishock JT, Katz DI. Update of neuropathology and neurological recovery after traumatic brain injury. J Head Trauma Rehabil. 2005; 20: 76-94.
13. Pudenz RH, Shelden CH. The lucite calvarium- A method for direct observation of the brain. J Neurosurg. 1946; 3: 487-505.
14. Gennarelli TA, Thibault LE, Adams JH, et al Diffuse axonal injury and traumatic coma in the primate. Ann Neurol. 1982; 12: 564-74.
15. Gennarelli TA. Head injury in man and experimental animals: clinical aspects. Acta Neurochir Suppl. 1983; 32: 1-13.
16. Gentry LR, Godersky JC, Thompson B. MR imaging of head trauma: review of the distribution and radiopathologic features of traumatic lesions. AJR Am J Roentgenol. 1988; 150: 663-72.
17. Strich SJ. Diffuse degeneration of the cerebral white matter in severe dementia following head injury. J Neurol Neurosurg Psychiatry. 1956; 19: 163-85.
18. Adams JH, Doyle D, Ford I, et al Diffuse axonal injury in head injury: definition, diagnosis and grading. Histopathology. 1989; 15: 49-59.
19. Gentry LR. Imaging of closed head injury. Radiology. 1994; 191: 1-17.
20. Dennerll TJ, Lamoureux P, Buxbaum RE, et al The cytomechanics of axonal elongation and retraction. J Cell Biol. 1989; 109: 3073-83.
21. Meythaler JM, Peduzzi JD, Eleftheriou E, et al Current concepts: diffuse axonal injury-associated traumatic brain injury. Arch Phys Med Rehabil. 2001; 82: 1461-71.
22. Meaney DF, Smith DH, Shreiber DI, et al Biomechanical analysis of experimental diffuse axonal injury. J Neurotrauma. 1995; 12: 689-94.
23. Tang-Schomer MD, Patel AR, Baas PW, et al Mechanical breaking of microtubules in axons during dynamic stretch injury underlies delayed elasticity, microtubule disassembly, and axon degeneration. FASEB J. 2009; 24: 1401-10.
24. Yoganandan N, Li J, Zhang J, et al Influence of angular acceleration-deceleration pulse shapes on regional brain strains. J Biomech. 2008; 41: 2253-62.
25. Yoganandan N, Gennarelli TA, Zhang J, et al Association of contact loading in diffuse axonal injuries from motor vehicle crashes. J Trauma. 2009; 66: 309-15.
26. Yoganandan N, Pintar FA, Stemper BD, et al Biomechanics of side impact: injury criteria, aging occupants, and airbag technology. J Biomech. 2007; 40: 227-43.
27. Katz DI, Alexander MP. Traumatic brain injury. Predicting course of recovery and outcome for patients admitted to rehabilitation. Arch Neurol. 1994; 51: 661-70.
28. Bigler ED. Anterior and middle cranial fossa in traumatic brain injury: relevant neuroanatomy and neuropathology in the study of neuropsychological outcome. Neuropsychology. 2007; 21: 515-31.
29. Wallesch CW, Curio N, Galazky I, et al The neuropsychology of blunt head injury in the early postacute stage: effects of focal lesions and diffuse axonal injury 4. J Neurotrauma. 2001; 18: 11-20.
30. Scheid R, Walther K, Guthke T, et al Cognitive sequelae of diffuse axonal injury. Arch Neurol. 2006; 63: 418-24.
31. Jang SH. Review of motor recovery in patients with traumatic brain injury. Neuro Rehabil. 2009; 24: 349-53.
32. Katz DI, Alexander MP, Klein RB. Recovery of arm function in patients with paresis after traumatic brain injury. Arch Phys Med Rehabil. 1998; 79: 488-93.
33. Katz DI, White DK, Alexander MP, et al Recovery of ambulation after traumatic brain injury. Arch Phys Med Rehabil. 2004; 85: 865-9.
34. Gentry LR, Godersky JC, Thompson B, et al Prospective comparative study of intermediate-field MR and CT in the evaluation of closed head trauma. AJR Am J Roentgenol. 1988; 150: 673-82.
35. Hesselink JR, Dowd CF, Healy ME, et al MR imaging of brain contusions: a comparative study with CT. AJR Am J Roentgenol. 1988; 150: 1133-42.
36. Li XY, Feng DF. Diffuse axonal injury: novel insights into detection and treatment. J Clin Neurosci. 2009; 16: 614-9.
37. Smith DH, Meaney DF, Shull WH. Diffuse axonal injury in head trauma. J Head Trauma Rehabil. 2003; 18: 307-16.
38. Le Bihan D. Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci. 2003; 4: 469-80.
39. Skandsen T, Kvistad KA, Solheim O, et al Prevalence and impact of diffuse axonal injury in patients with moderate and severe head injury: a cohort study of early magnetic resonance imaging findings and 1-year outcome. J Neurosurg. 2010; 113: 556-63.
40. Singleton RH, Povlishock JT. Identification and characterization of heterogeneous neuronal injury and death in regions of diffuse brain injury: evidence for multiple independent injury phenotypes. J Neurosci. 2004; 24: 3543-53.
41. Wang HC, Ma YB. Experimental models of traumatic axonal injury. J Clin Neurosci. 2010; 17: 157-62.
42. Bullock R, Zauner A, Woodward JJ, et al Factors affecting excitatory amino acid release following severe human head injury. J Neurosurg. 1998; 89: 507-18.
43. Bullock R, Zauner A, Myseros JS, et al Evidence for prolonged release of excitatory amino acids in severe human head trauma. Relationship to clinical events. Ann N Y Acad Sci. 1995; 765: 290-7.
44. Choi DW, Maulucci-Gedde M, Kriegstein AR. Glutamate neurotoxicity in cortical cell culture. J Neurosci. 1987; 7: 357-68.
45. Koura SS, Doppenberg EM, Marmarou A, et al Relationship between excitatory amino acid release and outcome after severe human head injury. Acta Neurochir Suppl. 1998; 71: 244-6.
46. Chamoun R, Suki D, Gopinath SP, et al Role of extracellular glutamate measured by cerebral microdialysis in severe traumatic brain injury. J Neurosurg. 2010; 113: 564-70.
47. Choi DW. Ionic dependence of glutamate neurotoxicity. J Neurosci. 1987; 7: 369-79.
48. Faden AI, Demediuk P, Panter SS, et al The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science. 1989; 244: 798-800.
49. Lee LL, Galo E, Lyeth BG, et al Neuroprotection in the rat lateral fluid percussion model of traumatic brain injury by SNX-185, an N-type voltage-gated calcium channel blocker. Exp Neurol. 2004; 190: 70-8.
50. Pike BR, Zhao X, Newcomb JK, et al Stretch injury causes calpain and caspase-3 activation and necrotic and apoptotic cell death in septo-hippocampal cell cultures. J Neurotrauma. 2000; 17: 283-98.
51. Griffith OW, Stuehr DJ. Nitric oxide synthases: properties and catalytic mechanism. Annu Rev Physiol. 1995; 57: 707-36.
52. Cherian L, Hlatky R, Robertson CS. Nitric oxide in traumatic brain injury. Brain Pathol. 2004; 14: 195-201.
53. Hall ED, Detloff MR, Johnson K, et al Peroxynitrite-mediated protein nitration and lipid peroxidation in a mouse model of traumatic brain injury. J Neurotrauma. 2004; 21: 9-20.
54. Arundine M, Aarts M, Lau A, et al Vulnerability of central neurons to secondary insults after in vitro mechanical stretch. J Neurosci. 2004; 24: 8106-23.
55. Mesenge C, Verrecchia C, Allix M, et al Reduction of the neurological deficit in mice with traumatic brain injury by nitric oxide synthase inhibitors. J Neurotrauma. 1996; 13: 11-6.
56. Wada K, Chatzipanteli K, Busto R, et al Role of nitric oxide in traumatic brain injury in the rat. J Neurosurg. 1998; 89: 807-18.
57. Merenda A, Bullock R. Clinical treatments for mitochondrial dysfunctions after brain injury. Curr Opin Crit Care. 2006; 12: 90-6.
58. Nicholls DG. A role for the mitochondrion in the protection of cells against calcium overload Prog Brain Res. 1985; 63: 97-106.
59. Xiong Y, Gu Q, Peterson PL, et al Mitochondrial dysfunction and calcium perturbation induced by traumatic brain injury. J Neurotrauma. 1997; 14: 23-34.
60. Bernardi P. Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore by the proton electrochemical gradient. Evidence that the pore can be opened by membrane depolarization. J Biol Chem. 1992; 267: 8834-9.
61. Scorrano L, Petronilli V, Bernardi P. On the voltage dependence of the mitochondrial permeability transition pore. A critical appraisal. J Biol Chem. 1997; 272: 12295-9.
62. Kristal BS, Dubinsky JM. Mitochondrial permeability transition in the central nervous system: induction by calcium cycling-dependent and -independent pathways. J Neurochem. 1997; 69: 524-38.
63. White RJ, Reynolds IJ. Mitochondrial depolarization in glutamate-stimulated neurons: an early signal specific to excitotoxin exposure. J Neurosci. 1996; 16: 5688-97.
64. Lifshitz J, Friberg H, Neumar RW, et al Structural and functional damage sustained by mitochondria after traumatic brain injury in the rat: evidence for differentially sensitive populations in the cortex and hippocampus. J Cereb Blood Flow Metab. 2003; 23: 219-31.
65. Singh IN, Sullivan PG, Deng Y, et al Time course of post-traumatic mitochondrial oxidative damage and dysfunction in a mouse model of focal traumatic brain injury: implications for neuroprotective therapy. J Cereb Blood Flow Metab. 2006; 26: 1407-18.
66. Verweij BH, Muizelaar JP, Vinas FC, et al Impaired cerebral mitochondrial function after traumatic brain injury in humans. J Neurosurg. 2000; 93: 815-20.
67. Marklund N, Salci K, Ronquist G, et al Energy metabolic changes in the early post-injury period following traumatic brain injury in rats. Neurochem Res. 2006; 31: 1085-93.
68. Signoretti S, Marmarou A, Aygok GA, et al Assessment of mitochondrial impairment in traumatic brain injury using high-resolution proton magnetic resonance spectroscopy. J Neurosurg. 2008; 108: 42-52.
69. Buki A, Okonkwo DO, Wang KK, et al Cytochrome c release and caspase activation in traumatic axonal injury. J Neurosci. 2000; 20: 2825-34.
70. Krajewski S, Krajewska M, Ellerby LM, et al Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc Natl Acad Sci USA. 1999; 96: 5752-7.
71. Robertson CL, Saraswati M, Fiskum G. Mitochondrial dysfunction early after traumatic brain injury in immature rats. J Neurochem. 2007; 101: 1248-57.
72. Maciel EN, Vercesi AE, Castilho RF. Oxidative stress in Ca(2+)-induced membrane permeability transition in brain mitochondria. J Neurochem. 2001; 79: 1237-45.
73. Kagan VE, Bayir HA, Belikova NA, et al Cytochrome c/cardiolipin relations in mitochondria: a kiss of death. Free Radic Biol Med. 2009; 46: 1439-53.
74. Kagan VE, Tyurin VA, Jiang J, et al Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol. 2005; 1: 223-32.
75. Bayir H, Tyurin VA, Tyurina YY, et al Selective early cardiolipin peroxidation after traumatic brain injury: an oxidative lipidomics analysis. Ann Neurol. 2007; 62: 154-69.
76. Kirkland RA, Adibhatla RM, Hatcher JF, et al Loss of cardiolipin and mitochondria during programmed neuronal death: evidence of a role for lipid peroxidation and autophagy. Neuroscience. 2002; 115: 587-602.
77. Bayir H, Kagan VE, Tyurina YY, et al Assessment of antioxidant reserves and oxidative stress in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatr Res. 2002; 51: 571-8.
78. Sullivan PG, Thompson MB, Scheff SW. Cyclosporin A attenuates acute mitochondrial dysfunction following traumatic brain injury. Exp Neurol. 1999; 160: 226-34.
79. Tenneti L, Lipton SA. Involvement of activated caspase-3-like proteases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons. J Neurochem. 2000; 74: 134-42.
80. Sullivan PG, Keller JN, Bussen WL, et al Cytochrome c release and caspase activation after traumatic brain injury. Brain Res. 2002; 949: 88-96.
81. Clark RS, Kochanek PM, Watkins SC, et al Caspase-3 mediated neuronal death after traumatic brain injury in rats. J Neurochem. 2000; 74: 740-53.
82. Liu X, Kim CN, Yang J, et al Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 1996; 86: 147-57.
83. Kruman II, Mattson MP. Pivotal role of mitochondrial calcium uptake in neural cell apoptosis and necrosis. J Neurochem. 1999; 72: 529-40.
84. Budd SL, Tenneti L, Lishnak T, et al Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons. Proc Natl Acad Sci USA. 2000; 97: 6161-6.
85. Huang Y, Wang KK. The calpain family and human disease. Trends Mol Med. 2001; 7: 355-62.
86. Clark RS, Kochanek PM, Chen M, et al Increases in Bcl-2 and cleavage of caspase-1 and caspase-3 in human brain after head injury. FASEB J. 1999; 13: 813-21.
87. Wang KK. Calpain and caspase: can you tell the difference Trends Neurosci. 2000; 23: 20-6.
88. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science. 1998; 281: 1305-8.
89. Saatman KE, Creed J, Raghupathi R. Calpain as a therapeutic target in traumatic brain injury. Neurotherapeutics. 2010; 7: 31-42.
90. Kampfl A, Posmantur R, Nixon R, et al mu-calpain activation and calpain-mediated cytoskeletal proteolysis following traumatic brain injury. J Neurochem. 1996; 67: 1575-83.
91. Saatman KE, Bozyczko-Coyne D, Marcy V, et al Prolonged calpain-mediated spectrin breakdown occurs regionally following experimental brain injury in the rat. J Neuropathol Exp Neurol. 1996; 55: 850-60.
92. Pike BR, Zhao X, Newcomb JK, et al Regional calpain and caspase-3 proteolysis of alpha-spectrin after traumatic brain injury. Neuroreport. 1998; 9: 2437-42.
93. Pike BR, Flint J, Dutta S, et al Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats. J Neurochem. 2001; 78: 1297-306.
94. Farkas O, Polgar B, Szekeres-Bartho J, et al Spectrin breakdown products in the cerebrospinal fluid in severe head injury - preliminary observations. Acta Neurochir. 2005; 147: 855-61.
95. Yamashima T, Tonchev AB, Tsukada T, et al Sustained calpain activation associated with lysosomal rupture executes necrosis of the postischemic CA1 neurons in primates. Hippocampus. 2003; 13: 791-800.
96. 2+-dependent proteases in ischemic neuronal death: a conserved 'calpain-cathepsin cascade' from nematodes to primates. Cell Calcium. 2004; 36: 285-93.
97. De Duve C, Wattiaux R. Functions of lysosomes. Annu Rev Physiol. 1966; 28: 435-92.
98. Chua BT, Guo K, Li P. Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases. J Biol Chem. 2000; 275: 5131-5.
99. Saatman KE, Murai H, Bartus RT, et al Calpain inhibitor AK295 attenuates motor and cognitive deficits following experimental brain injury in the rat. Proc Natl Acad Sci USA. 1996; 93: 3428-33.
100. Raghupathi R, Mehr MF, Helfaer MA, et al Traumatic axonal injury is exacerbated following repetitive closed head injury in the neonatal pig. J Neurotrauma. 2004; 21: 307-16.
101. Rink A, Fung KM, Trojanowski JQ, et al Evidence of apoptotic cell death after experimental traumatic brain injury in the rat. Am J Pathol. 1995; 147: 1575-83.
102. Ankarcrona M, Dypbukt JM, Bonfoco E, et al Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron. 1995; 15: 961-73.
103. Choi DW. Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci. 1995; 18: 58-60.
104. Zipfel GJ, Babcock DJ, Lee JM, et al Neuronal apoptosis after CNS injury: the roles of glutamate and calcium. J Neurotrauma. 2000; 17: 857-69.
105. Geddes JF, Whitwell HL, Graham DI. Traumatic axonal injury: practical issues for diagnosis in medicolegal cases. Neuropathol Appl Neurobiol. 2000; 26: 105-16.
106. Oppenheimer DR. Microscopic lesions in the brain following head injury. J Neurol Neurosurg Psychiatry. 1968; 31: 299-306.
107. Strich SJ, Oxon DM. Shearing of nerve fibers as a cause of brain damage due to head injury. Lancet. 1961; 443-8.
108. Povlishock JT. Pathobiology of traumatically induced axonal injury in animals and man. Ann Emerg Med. 1993; 22: 980-6.
109. Povlishock JT, Jenkins LW. Are the pathobiological changes evoked by traumatic brain injury immediate and irreversible Brain Pathol. 1995; 5: 415-26.
110. Farkas O, Povlishock JT. Cellular and subcellular change evoked by diffuse traumatic brain injury: a complex web of change extending far beyond focal damage. Prog Brain Res. 2007; 161: 43-59.
111. Pettus EH, Christman CW, Giebel ML, et al Traumatically induced altered membrane permeability: its relationship to traumatically induced reactive axonal change. J Neurotrauma. 1994; 11: 507-22.
112. Maxwell WL, Graham DI. Loss of axonal microtubules and neurofilaments after stretch-injury to guinea pig optic nerve fibers. J Neurotrauma. 1997; 14: 603-14.
113. Maxwell WL, Domleo A, McColl G, et al Post-acute alterations in the axonal cytoskeleton after traumatic axonal injury. J Neurotrauma. 2003; 20: 151-68.
114. McGinn MJ, Kelley BJ, Akinyi L, et al Biochemical, structural, and biomarker evidence for calpain-mediated cytoskeletal change after diffuse brain injury uncomplicated by contusion. J Neuropathol Exp Neurol. 2009; 68: 241-9.
115. Stone JR, Singleton RH, Povlishock JT. Intra-axonal neurofilament compaction does not evoke local axonal swelling in all traumatically injured axons. Exp Neurol. 2001; 172: 320-31.
116. Stone JR, Okonkwo DO, Dialo AO, et al Impaired axonal transport and altered axolemmal permeability occur in distinct populations of damaged axons following traumatic brain injury. Exp Neurol. 2004; 190: 59-69.
117. Marmarou CR, Walker SA, Davis CL, et al Quantitative analysis of the relationship between intra- axonal neurofilament compaction and impaired axonal transport following diffuse traumatic brain injury. J Neurotrauma. 2005; 22: 1066-80.
118. DiLeonardi AM, Huh JW, Raghupathi R. Impaired axonal transport and neurofilament compaction occur in separate populations of injured axons following diffuse brain injury in the immature rat. Brain Res. 2009; 1263: 174-82.
119. Stone JR, Singleton RH, Povlishock JT. Antibodies to the C-terminus of the beta-amyloid precursor protein (APP): a site specific marker for the detection of traumatic axonal injury 6. Brain Res. 2000; 871: 288-302.
120. Gentleman SM, Roberts GW, Gennarelli TA, et al Axonal injury: a universal consequence of fatal closed head injury Acta Neuropathol Berl. 1995; 89: 537-43.
121. Marmarou CR, Povlishock JT. Administration of the immunophilin ligand FK506 differentially attenuates neurofilament compaction and impaired axonal transport in injured axons following diffuse traumatic brain injury. Exp Neurol. 2006; 197: 353-62.
122. Reeves TM, Phillips LL, Povlishock JT. Myelinated and unmyelinated axons of the corpus callosum differ in vulnerability and functional recovery following traumatic brain injury. Exp Neurol. 2005; 196: 126-37.
123. Reeves TM, Phillips LL, Lee NN, et al Preferential neuroprotective effect of tacrolimus (FK506) on unmyelinated axons following traumatic brain injury. Brain Res. 2007; 1154: 225-36.
124. Kelley BJ, Farkas O, Lifshitz J, et al Traumatic axonal injury in the perisomatic domain triggers ultrarapid secondary axotomy and Wallerian degeneration. Exp Neurol. 2006; 198: 350-60.
125. Erb DE, Povlishock JT. Neuroplasticity following traumatic brain injury: a study of GABAergic terminal loss and recovery in the cat dorsal lateral vestibular nucleus. Exp Brain Res. 1991; 83: 253-67.
126. Buki A, Povlishock JT. All roads lead to disconnection? Traumatic axonal injury revisited. Acta Neurochir. 2006; 148: 181-93.
127. Prins ML, Povlishock JT, Phillips LL. The effects of combined fluid percussion traumatic brain injury and unilateral entorhinal deafferentation on the juvenile rat brain. Brain Res Dev Brain Res. 2003; 140: 93-104.
128. Falo MC, Fillmore HL, Reeves TM, et al Matrix metalloproteinase-3 expression profile differentiates adaptive and maladaptive synaptic plasticity induced by traumatic brain injury. J Neurosci Res. 2006; 84: 768-81.
129. Falo MC, Reeves TM, Phillips LL. Agrin expression during synaptogenesis induced by traumatic brain injury. J Neurotrauma. 2008; 25: 769-83.
130. Singleton RH, Zhu J, Stone JR, et al Traumatically induced axotomy adjacent to the soma does not result in acute neuronal death. J Neurosci. 2002; 22: 791-802.
131. Wang KK, Larner SF, Robinson G, et al Neuroprotection targets after traumatic brain injury. Curr Opin Neurol. 2006; 19: 514-9.
132. Af Geijerstam JL, Britton M. Mild head injury - mortality and complication rate: meta-analysis of findings in a systematic literature review. Acta Neurochir. 2003; 145: 843-50.
133. Smits M, Dippel DW, Steyerberg EW, et al Predicting intracranial traumatic findings on computed tomography in patients with minor head injury: the CHIP prediction rule. Ann Intern Med. 2007; 146: 397-405.
134. Edwards P, Arango M, Balica L et al Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet. 2005; 365: 1957-9.
135. Fabbri A, Servadei F, Marchesini G, et al Early predictors of unfavourable outcome in subjects with moderate head injury in the emergency department. J Neurol Neurosurg Psychiatry. 2008; 79: 567-73.
136. Marshall LF, Gautille T, Klauber MR, et al The outcome of severe closed head injury. J Neurosurg. 1991; 75: s29-37.
137. Adams JH, Graham DI, Jennett B. The neuropathology of the vegetative state after an acute brain insult. Brain. 2000; 123: 1327-38.
138. Iverson GL. Outcome from mild traumatic brain injury. Curr Opin Psychiatry. 2005; 18: 301-17.
139. Ahmed S, Bierley R, Sheikh JI, et al Post-traumatic amnesia after closed head injury: a review of the literature and some suggestions for further research. Brain Inj. 2000; 14: 765-80.
140. Niogi SN, Mukherjee P, Ghajar J, et al Structural dissociation of attentional control and memory in adults with and without mild traumatic brain injury. Brain. 2008.